Ipilimumab vs Lorazepam
Ipilimumab vs Lorazepam: Overview
This comparison examines the pharmacological differences between Ipilimumab and Lorazepam.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Lorazepam: Intermediate-acting benzodiazepine enhancing GABA-A receptor chloride conductance.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Lorazepam — 10-20 hours.
Chemical Properties
Molecular Formula: Lorazepam — C15H10Cl2N2O2.
Molecular Weight: Lorazepam — 321.1580 g/mol.
Type: Ipilimumab — Antibody; Lorazepam — Small molecule.